| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |